Showing results (81-90 of 295) with videos related to
Sort By:
Pageof 30
Internal Medicine (Tokyo, Japan)|May 1, 2022
Pipeline Esophagogastric Varices Secondary to Extrahepatic Portal Vein Obstruction Treated Endoscopically with the Assistance of Transileocolic ObliterationShinya Yokoyama, Yoji Ishizu, Takashi Honda, et al.Journal of Gastroenterology and Hepatology|February 28, 2018
Impact of myosteatosis on skeletal muscle volume loss in patients with chronic liver diseaseYoshihiko Tachi, Akihiro Kozuka, Takanori Hirai, et al.Nutrition (Burbank, Los Angeles County, Calif.)|August 16, 2022
Factors associated with the progression of myosteatosis in patients with cirrhosisYoji Ishizu, Masatoshi Ishigami, Takashi Honda, et al.Journal of Gastroenterology and Hepatology|August 4, 2020
The relationship between oral-origin bacteria in the fecal microbiome and albumin-bilirubin grade in patients with hepatitis CKenta Yamamoto, Takashi Honda, Takanori Ito, et al.Hepatology International|February 10, 2019
Influence of proton pump inhibitors on microbiota in chronic liver disease patientsKenta Yamamoto, Masatoshi Ishigami, Takashi Honda, et al.European Journal of Gastroenterology & Hepatology|May 5, 2018
Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological responseYoshihiko Tachi, Takanori Hirai, Yuko Kojima, et al.Cancers|May 11, 2024
Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular CarcinomaYosuke Inukai, Kenta Yamamoto, Takashi Honda, et al.Anticancer Research|February 5, 2020
Relationship Between Adverse Events and Microbiomes in Advanced Hepatocellular Carcinoma Patients Treated With SorafenibKenta Yamamoto, Teiji Kuzuya, Takashi Honda, et al.Journal of Medical Ultrasonics (2001)|July 26, 2018
Transabdominal ultrasound elastography of the esophagogastric junction predicts reflux esophagitisHiroki Suhara, Yoshiki Hirooka, Hiroki Kawashima, et al.Antiviral Therapy|September 3, 2016
Liver fibrosis indices for identifying patients at low risk of developing hepatocellular carcinoma after eradication of HCVHidenori Toyoda, Toshifumi Tada, Yoshihiko Tachi, et al.Pageof 30